BU-NOT-SET
Recipharm is committed to achieve Net Zero carbon emissions by 2050.
This goal reflects our dedication to sustainability and responsibility towards our planet. We recognise the urgent need to address climate change and are taking decisive steps to reduce our carbon footprint. By adopting innovative practices, investing in renewable energy and enhancing our operational efficiency, we aim to minimise our environmental impact.
To meet our 2050 Net Zero goal, we have put in place specific milestones:
- Net Zero Scope 2 GHG emissions by 2030
- Net Zero Scope 1 GHG emissions by 2040
- Net Zero Scope 3 GHG emissions by 2050
In support of these long-term targets, we have set shorter-term objectives, validated by the Science Based Targets initiative (SBTi). We are committed to:
- Reduce absolute Scope 1 and 2 GHG emissions by 42.1% by 2030 from a 2021 base year
- 100% renewable electricity by the end of 2024
- Reduce absolute Scope 3 GHG emissions by 25% by 2030 from a 2021 base year (including, but not limited to, purchased goods and services, fuel and energy related activities, upstream transportation and distribution, waste generated in operations)
We regularly monitor our progress and reaffirm our commitment to elevate our environmental performance. For example, our CDP Climate rating improved from B- to B in 2023, a score exceeding both the global average and the Biotech & Pharma sector average.